{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:46:45Z","timestamp":1790192805144,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T00:00:00Z","timestamp":1499126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Dutch Kidney Foundation","doi-asserted-by":"publisher","award":["13OI116"],"award-info":[{"award-number":["13OI116"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/ndt\/gfx196","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T15:11:02Z","timestamp":1493133062000},"page":"635-645","source":"Crossref","is-referenced-by-count":51,"title":["Safety and effectiveness of restrictive eculizumab treatment in atypical haemolytic uremic syndrome"],"prefix":"10.1093","volume":"33","author":[{"given":"Kioa L","family":"Wijnsma","sequence":"first","affiliation":[{"name":"Department of Pediatric Nephrology, Radboud University Medical Center Amalia Children\u2019s Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Duineveld","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B","family":"Volokhina","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Radboud University Medical Center Amalia Children\u2019s Hospital, Nijmegen, The Netherlands"},{"name":"Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus P","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Radboud University Medical Center Amalia Children\u2019s Hospital, Nijmegen, The Netherlands"},{"name":"Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Pediatrics, University Hospital Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C A J","family":"van de Kar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Radboud University Medical Center Amalia Children\u2019s Hospital, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F M","family":"Wetzels","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"key\n\t\t\t\t20180402200333_gfx196-B1","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2015-03-569277","article-title":"HUS and the case for complement","volume":"126","author":"Conway","year":"2015","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical hemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"Greenbaum","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B6","author":"European Medicines Agency"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12347","article-title":"Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria","volume":"162","author":"Hillmen","year":"2013","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00467-014-2990-5","article-title":"Eculizumab hepatotoxicity in pediatric aHUS","volume":"30","author":"Hayes","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B11","author":"National Institute for Health and Care Excellence","year":"2015"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jth.12764","article-title":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment","volume":"13","author":"Cugno","year":"2015","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/j.ajkd.2014.01.434","article-title":"Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases","volume":"64","author":"Ardissino","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B14","doi-asserted-by":"crossref","first-page":"342.","DOI":"10.1053\/j.ajkd.2014.04.039","article-title":"Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome","volume":"65","author":"Wetzels","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B15","first-page":"45","article-title":"Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report","volume":"3","author":"Ohanian","year":"2011","journal-title":"Clin Pharmacol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00277-013-1972-1","article-title":"Successful discontinuation of eculizumab therapy in a patient with aHUS","volume":"93","author":"Pu","year":"2014","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.ajkd.2015.04.010","article-title":"Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update","volume":"66","author":"Ardissino","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.clim.2015.05.018","article-title":"Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome","volume":"160","author":"Volokhina","year":"2015","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2215\/CJN.06440616","article-title":"Pathogenic variants in complement genes and risk of atypical hemolytic uremic syndrome relapse after eculizumab discontinuation","volume":"12","author":"Fakhouri","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/hcv082","article-title":"A national specialized service in England for atypical haemolytic uraemic syndrome-the first year's experience","volume":"109","author":"Sheerin","year":"2016","journal-title":"QJM"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B21","first-page":"342","article-title":"Living kidney transplantation in adult patients with atypical haemolytic uraemic syndrome","volume":"71","author":"Verhave","year":"2013","journal-title":"Neth J Med"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B23","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B25","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molimm.2015.02.013","article-title":"Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients","volume":"65","author":"Mohlin","year":"2015","journal-title":"Mol Immunol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B27","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B28","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/humu.9408","article-title":"De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome","volume":"27","author":"Heinen","year":"2006","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B29","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1681\/ASN.2013121339","article-title":"A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation","volume":"26","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies","volume":"12","author":"Durey","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B33","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","article-title":"Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics","volume":"27","author":"Geerdink","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B35","doi-asserted-by":"crossref","first-page":"i115","DOI":"10.1093\/ndt\/gfw353","article-title":"Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome","volume":"32","author":"van den Brand","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B36","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180402200333_gfx196-B37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/cei.12426","article-title":"Complement activation patterns in atypical haemolytic uraemic syndrome during acute phase and in remission","volume":"181","author":"Volokhina","year":"2015","journal-title":"Clin Exp Immunol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/4\/635\/24524994\/gfx196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T20:03:46Z","timestamp":1522699426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/4\/635\/3922789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,4]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx196","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732086194.793565317","asserted-by":"object"}]},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2017,7,4]]}}}